Lotz Christopher L. 4
4 · Qualigen Therapeutics, Inc. · Filed Jun 8, 2020
Insider Transaction Report
Form 4
Lotz Christopher L.
VP of Finance, CFO.
Transactions
- Award
Stock Option (Right to Buy)
2020-06-06+600,000→ 600,000 totalExercise: $5.13Exp: 2030-06-06→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]Shares underlying the stock option vest over three years in equal annual installments from the date of grant.